| Sandoz Pharmaceuticals AG - Naropin 5 mg/ml, Injektionslösung |
| 54015 | | 04 | | Naropin 5 mg/ml | | Injektionslösung | | N01BB09 | | Ropivacaine | | 26.02.2001 | | |
|
| Composition |
| ropivacaini hydrochloridum 5 mg corresp. ropivacainum 4.42 mg, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium max. 3.5 mg. |
| Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
|---|
| Ropivacaine Hydrochloride | 5 mg/ml correspond Ropivacaine 4.42 mg/ml |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Sodium Chloride | | Sodium Hydroxide |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | 5 x 10 ml | | | B | | Yes |
|
